Detalhe da pesquisa
1.
Increased Serum Levels of α-Synuclein in Patients With Major Depressive Disorder.
Am J Geriatr Psychiatry
; 27(3): 280-286, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30503177
2.
Serum levels and mutual correlations of amyloid ß in patients with depression.
Geriatr Gerontol Int
; 20(2): 125-129, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31833164
3.
Serum levels of TDP-43 in late-life patients with depressive episode.
J Affect Disord
; 250: 284-288, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30875670
4.
Glucocorticoid may influence amyloid ß metabolism in patients with depression.
Psychiatry Res
; 259: 191-196, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29073556
5.
Residual memory impairment in remitted depression may be a predictive factor for recurrence.
J Clin Psychiatry
; 77(2): 247-51, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26930522
6.
Psychomotor agitation in major depressive disorder is a predictive factor of mood-switching.
J Affect Disord
; 170: 185-9, 2015 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25248024
7.
Gender differences in serum testosterone and cortisol in patients with major depressive disorder compared with controls.
Int J Psychiatry Med
; 46(2): 203-21, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24552043
8.
Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (S) levels in medicated patients with major depressive disorder compared with controls.
J Affect Disord
; 146(2): 205-12, 2013 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23102506